Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
2
×
boston blog main
2
×
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
spark therapeutics
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alopecia areata
amarin
ambys medicines
amgen
What
bio
drug
2
×
patients
2
×
roundup
advantages
aren’t
bar
brings
developers
drugs
expect
fda
gamble
gene
help
imminent
long
market
medco’s
medicare
mover
moves
new
news
noteworthy
payers
physicians
plan
prices
pricing
road
rulings
separate
sets
therapy
they’ll
type
ubiome
undone
vertex’s
Language
unset
Current search:
drug
×
patients
×
" boston blog main "
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More